COMMUNIQUÉS West-GlobeNewswire

ObsEva SA Achieves Primary and Secondary Endpoints for EDELWEISS Phase 2b Clinical Trial of Linzagolix (OBE2109) in Women with Endometriosis
18/06/2018
Partial suppression of estradiol with moderate dose (75mg) of linzagolix demonstrated highly significant reduction of pain and improvement of patient well-being High dose (200mg) of linzagolix achieves full estradiol [...]
Rhythm Pharmaceuticals Announces New Topline Clinical Data from Ongoing Phase 2 Basket Studies Evaluating Setmelanotide in Rare Genetic Disorders of Obesity
18/06/2018
-- Further Improvements Observed in Bardet-Biedl Syndrome Patients; Initial Proof-of-Concept Data in Alström Syndrome Demonstrates Significant Weight Loss and Decreased Hunger -- -- Rhythm Plans to Initiate Combined [...]
Sunesis Pharmaceuticals Announces Presentations at the EHA Annual Meeting
18/06/2018
Université Claude Bernard de Lyon Study Provides Preclinical Validation of Vecabrutinib Activity Against Ibrutinib-Resistant BTK C481S Mutated Lymphomas ERIC Study Shows Half of Ibrutinib-Relapse CLL Patients Carry BTK [...]
The Dementia Discovery Fund and Immuneering announce a Research Collaboration to identify novel drug targets and drug candidates for Alzheimer's disease
18/06/2018
The Dementia Discovery Fund and Immuneering announce a Research Collaboration to identify novel drug targets and drug candidates for Alzheimer's disease Cambridge, MA and London, 18 June 2018 - The Dementia Discovery [...]
Stemline Therapeutics Announces Positive Clinical Data from ELZONRISTM (tagraxofusp; SL-401) Trials in BPDCN, CMML and MF Delivered at the EHA Congress
18/06/2018
NEW YORK, June 18, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing novel oncology therapeutics, announced today that positive clinical data from [...]
Lexicon Pharmaceuticals to Present New Clinical Data at 78th American Diabetes Association Scientific Sessions
18/06/2018
THE WOODLANDS, Texas, June 18, 2018 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq:LXRX), today announced that new clinical data for sotagliflozin will be presented at the upcoming 78 th American Diabetes [...]
Agios Announces Initiation of Global Phase 3 Trial (ACTIVATE) of AG-348 in Adults with Pyruvate Kinase Deficiency Who Are Not Regularly Transfused
18/06/2018
- Broad Late-stage Development Plan in Place with Two Pivotal Trials and Patient Registry Open for Enrollment - CAMBRIDGE, Mass., June 18, 2018 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in [...]
Microbot Medical Inc. Announces European Patent Office's Intent to Grant Patent for Device for the Prevention of Shunt Stenosis
18/06/2018
HINGHAM, Mass., June 18, 2018 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq CM:MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, today [...]
Solid Biosciences Announces FDA Removes Clinical Hold on SGT-001
18/06/2018
- Activities to Resume Enrollment in IGNITE DMD Phase I/II Clinical Trial are Underway - Conference Call Scheduled for Today at 8:30 A.M. ET CAMBRIDGE, Mass., June 18, 2018 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. ( [...]
Urgent need for blood donors by Canada Day
18/06/2018
More than 23,000 donors across Canada needed by July 2 OTTAWA, June 18, 2018 (GLOBE NEWSWIRE) -- Canadian Blood Services is urging Canadians to help meet patients’ needs this summer by donating blood and by encouraging [...]
Urgent besoin de donneurs de sang d’ici la fête du Canada
18/06/2018
Les centres de collecte du pays ont besoin de plus de 23 000 donneurs d’ici le 2 juillet OTTAWA, 18 juin 2018 (GLOBE NEWSWIRE) -- La Société canadienne du sang demande aux Canadiens de donner du sang et d’encourager les [...]
Auxly Announces Signing of Definitive Joint Venture Agreement With Peter Quiring to Build State-Of-The-Art 1.4 Million Square Foot Greenhouse
18/06/2018
VANCOUVER, British Columbia, June 18, 2018 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX-V:XLY) (" Auxly " or the " Company ") is pleased to announce that further to its previously announced transaction on February [...]
BeyondSpring to Host First-Quarter 2018 Financial Results Conference Call on June 21, 2018
18/06/2018
NEW YORK, June 18, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc . (NASDAQ:BYSI), a global, clinical-stage biopharmaceutical company focused on the development of transformative cancer therapies, today announced that the [...]
Geron Reports Imetelstat Oral Presentation at European Hematology Association Congress
18/06/2018
Updated Clinical Data from Original Part 1 of IMerge in Myelodysplastic Syndromes (MDS) Presented MENLO PARK, Calif., June 18, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced the oral [...]
Quotient Limited Reports Concordance Data from the MosaiQ European Field Trial
18/06/2018
Field trial concordance data exceed targeted criteria Planned issuance of $36 million in Senior Secured Notes JERSEY, Channel Islands, June 18, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage [...]
Catalyst Biosciences Provides Update on CB 2679d/ISU304 Factor IX Clinical Program in Hemophilia B
18/06/2018
Conference call and webcast to be held today, June 18, 2018 at 8:30 a.m. EDT SOUTH SAN FRANCISCO, Calif., June 18, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (Nasdaq:CBIO), a clinical-stage biopharmaceutical [...]
Arrayit Corporation Announces Nationwide Allergy Testing Sales and Distribution Network
18/06/2018
Sunnyvale, June 18, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation Announces Nationwide Allergy Testing Sales and Distribution Network June 18, 2018 - Sunnyvale, CA – Arrayit Corporation (OTC: ARYC ), a life sciences and [...]
Solon Eiendom ASA : New share capital registered
18/06/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR [...]
Transactions under Novozymes’ stock buyback program
18/06/2018
Please read the full announcement in the attached PDF Attachment 2018_39_Stock_Buybackprogram_EN

Pages